Lasa Supergenerics Key Ratios
NSE: LASA | BSE: 540702
₹4.01
As on 16-Nov-2026IST
Market cap
₹22 Cr
Revenue (TTM)
₹6 Cr
P/E Ratio
--
P/B Ratio
0.5
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 1,029.55 | -93.87 | -95.17 | -63.55 | -48.98 |
| EBIT | 13.71 | -42.71 | -100.70 | -57.59 | -190.01 |
| Net Profit | 16.16 | -67.63 | -156.18 | -5.35 | -196.92 |
| EPS | 14.08 | 83.05 | 50.06 | 14.86 | -194.10 |
| Book Value | -- | -- | -40.72 | -25.14 | -24.00 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| -21.79 | -15.94 | -224.58 | -53.10 | -4.16 |
| Net Margin
| -55.11 | -39.72 | -253.90 | -134.53 | -10.01 |
| Return on equity
| -29.24 | -23.81 | -29.40 | -51.13 | -16.36 |
| Return on Capital
| -25.51 | -20.78 | -- | -47.09 | -16.21 |
| Return on Assets
| -22.04 | -17.88 | -19.73 | -40.63 | -11.69 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.20 | 0.03 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
-47.09
|
-16.21
|
-13.23
|
-23.94
|
|
Peer Median
|
--
|
12.41
|
16.46
|
15.49
|
--
|
ROE
-29.40
Lower than Peers by 38.48
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-29.40
|
-51.13
|
-16.36
|
-20.22
|
-27.97
|
|
Peer Median
|
9.08
|
13.36
|
13.87
|
14.72
|
--
|
ROA
-19.73
Lower than Peers by 27.00
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-19.73
|
-40.63
|
-11.69
|
-13.81
|
-20.71
|
|
Peer Median
|
7.27
|
7.23
|
8.04
|
7.19
|
--
|
EBIT Margin
-224.58
Lower than Peers by 233.83
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-224.58
|
-53.10
|
-4.16
|
-8.10
|
-15.45
|
|
Peer Median
|
9.25
|
17.33
|
10.05
|
10.28
|
--
|
Net Margin
-253.90
Lower than Peers by 262.36
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-253.90
|
-134.53
|
-10.01
|
-20.81
|
-29.39
|
|
Peer Median
|
8.46
|
11.16
|
9.11
|
6.78
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
0.00
|
-111.66
|
-1.73
|
-10.60
|
-19.45
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-95.17
Lower than Peers by 101.81
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-95.17
|
-82.35
|
36.53
|
-19.47
|
-5.51
|
|
Peer Median
|
6.64
|
26.57
|
7.17
|
10.56
|
--
|
EBIT Growth
-100.70
Lower than Peers by 100.39
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-100.70
|
-125.20
|
29.84
|
57.79
|
-1,428.98
|
|
Peer Median
|
-0.31
|
31.63
|
12.05
|
6.17
|
--
|
Net Profit Growth
-156.18
Lower than Peers by 163.76
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-156.18
|
-131.01
|
32.09
|
43.73
|
-624.41
|
|
Peer Median
|
7.58
|
26.27
|
22.15
|
27.97
|
--
|
EPS Growth
50.06
Higher than Peers by 48.97
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
50.06
|
-131.01
|
32.09
|
43.73
|
-624.42
|
|
Peer Median
|
1.08
|
24.54
|
8.80
|
--
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
-40.72
|
-13.41
|
-18.27
|
-25.08
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
0.20
|
0.03
|
0.23
|
0.18
|
|
Peer Median
|
0.02
|
0.17
|
0.03
|
0.05
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
0.20
|
0.03
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.62
Lower than Peers by 1.78
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
0.62
|
0.62
|
1.90
|
0.78
|
0.92
|
|
Peer Median
|
2.40
|
2.09
|
2.20
|
1.93
|
--
|
Quick Ratio
0.51
Lower than Peers by 1.19
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
0.51
|
0.51
|
0.47
|
0.39
|
0.59
|
|
Peer Median
|
1.71
|
1.62
|
1.72
|
1.59
|
--
|
Interest Coverage
-30.16
Lower than Peers by 39.95
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-30.16
|
-81.54
|
-5.93
|
-8.60
|
-9.09
|
|
Peer Median
|
9.79
|
10.26
|
12.28
|
12.45
|
--
|
Operating Efficiency
Debtors to sales
0.65
Lower than Peers by 26.39
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
0.65
|
0.16
|
1.05
|
3.44
|
1.91
|
|
Peer Median
|
27.04
|
32.97
|
26.23
|
23.97
|
--
|
Asset Turnover
0.08
Lower than Peers by 0.61
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
0.08
|
0.30
|
1.13
|
0.66
|
0.69
|
|
Peer Median
|
0.69
|
0.65
|
0.74
|
0.88
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
11.13
|
6.51
|
10.61
|
29.63
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
191.01
|
55.78
|
57.63
|
35.78
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
94.45
|
41.71
|
56.97
|
45.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
107.68
|
20.58
|
11.27
|
20.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-1.35
Lower than Peers by 41.93
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-1.35
|
--
|
--
|
--
|
--
|
|
Peer Median
|
40.58
|
42.93
|
39.17
|
40.74
|
--
|
Price / Book Value
0.47
Lower than Peers by 3.29
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
0.47
|
0.57
|
1.01
|
1.14
|
0.78
|
|
Peer Median
|
3.76
|
4.60
|
3.61
|
3.87
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.10
|
0.10
|
0.19
|
0.20
|
--
|
EV/EBITDA
-3.80
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
-3.80
|
-5.26
|
7.53
|
56.20
|
-23.51
|
|
Peer Median
|
--
|
39.90
|
28.79
|
25.41
|
--
|
Market Cap
22
Lower than Peers by 5,265
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Lasa Supergenerics
|
22
|
28
|
84
|
110
|
93
|
|
Peer Median
|
5,287
|
5,287
|
3,944
|
2,959
|
--
|